vanderbilt brain institute
NYU’s Tsien to discuss brain plasticity at next Discovery Lecture
Mar. 29, 2021—Richard Tsien, PhD, director of the Neuroscience Institute at NYU Langone Medical Center, will deliver the next web-based Discovery Lecture.
Vanderbilt Brain Institute hosts Brain Blast 2021
Mar. 16, 2021—Brain Awareness Week is March 15–21, and the Vanderbilt Brain Institute will host Brain Blast, its annual outreach event. This year’s event will be entirely virtual, so participants can explore Brain Blast activities and videos from any location.
Bruce Carter joins CMT Research Foundation scientific advisory board
Feb. 12, 2021—Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease.
Inflammation in genetic epilepsy
Jan. 21, 2021—Brain inflammation links genetic and acquired epilepsy — providing new clues about epilepsy development and pointing to potential treatments.
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
Nov. 17, 2020—Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research.
Histamine circuits in brain reward center
Oct. 29, 2020—Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction.
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease—too much of a good thing
Oct. 27, 2020—Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people.
New faculty Rick Sando: A better understanding of brain circuitry
Oct. 26, 2020—New Assistant Professor of Pharmacology Rick Sando is interested in how neural circuits carry out specific functions when activated—and why these processes sometimes go awry.
Turning Heads: The Vanderbilt Brain Institute has emerged as a hub of discovery as neuroscience’s influence expands
Aug. 5, 2020—The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella.
The discovery of a ‘negative regulator’ in the brain alters understanding of brain function and potential treatment of cognitive disorders
Jul. 21, 2020—Terunaga Nakagawa and the Vanderbilt Brain Institute discover new qualities of GSG1L, responsible for activity in the anterior thalamus.
Neuroscientists at Vanderbilt identify the brain cells that help humans adapt to change
Jul. 15, 2020—New research on cognitive flexibility points to a small class of brain cells that support switching attention strategies when old strategies fail.
Save the date: VU-VUMC Neuroimaging Symposium set for May 22
Feb. 20, 2020—The Vanderbilt University Institute of Imaging Science and the Vanderbilt Brain Institute will co-host the first joint VU-VUMC Neuroimaging Symposium on Friday, May 22, at Vanderbilt Law School.